Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Vaccination for the post-kidney transplant population

Jain, Shilpa R.; Kumar, Deepali

Current Opinion in Nephrology and Hypertension: November 2019 - Volume 28 - Issue 6 - p 581–586
doi: 10.1097/MNH.0000000000000546
DIALYSIS AND TRANSPLANTATION: Edited by Anil Chandraker and J. Kevin Tucker

Purpose of review Kidney transplant recipients are at high risk of contracting infections, some of which are considered vaccine-preventable, because of their highly immunosuppressed state. In this vulnerable group of patients, infection can lead to poor outcomes including graft failure and death, thus vaccination in the posttransplant population is an important strategy in order to mitigate this risk. The present review is aimed at providing an update on recent advances with respect to vaccination strategies in kidney transplant recipients.

Recent findings General principles behind vaccination in kidney transplantation have remained consistent over many years. More recently, efforts have been focused on developing newer strategies for vaccination against influenza and herpes zoster in organ transplant recipients. Newer data on the immunogenicity of vaccines directed against pneumococcal disease, human papillomavirus, and hepatitis B virus in kidney transplant recipients have become available and will also be discussed in the present review.

Summary Kidney transplant recipients are highly-vulnerable to contracting serious infections by way of their immunosuppressed state and their dampened ability to mount an immunogenic response to vaccines. Thus, ongoing advances in vaccination strategies in this group of patients should be an important area of focus of future research in order to help promote healthier living and greater survival postkidney transplant.

Transplant Infectious Diseases, University Health Network, Toronto, Canada

Correspondence to Deepali Kumar, 585 University Avenue, 11-PMB-174, Toronto, ON M5G 2N2, Canada. Tel: +1 416 340 4241; e-mail:

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.